Large cancer cell line collections broadly capture the genomic diversity of human cancers
and provide valuable insight into anti-cancer drug response. Here we show substantial
agreement and biological consilience between drug sensitivity measurements and their
associated genomic predictors from two publicly available large-scale pharmacogenomics
resources: The Cancer Cell Line Encyclopedia and the Genomics of Drug Sensitivity in
Cancer databases.